583 related articles for article (PubMed ID: 317105)
1. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
Curran RC; Jones EL
J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin's disease: an immunohistochemical and histological study.
Curran RC; Jones EL
J Pathol; 1978 May; 125(1):39-51. PubMed ID: 569193
[TBL] [Abstract][Full Text] [Related]
3. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
4. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
5. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases.
Macon WR; Williams ME; Greer JP; Stein RS; Collins RD; Cousar JB
Am J Surg Pathol; 1992 Apr; 16(4):351-63. PubMed ID: 1373580
[TBL] [Abstract][Full Text] [Related]
6. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
8. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
9. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
Timens W; Visser L; Poppema S
Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
[TBL] [Abstract][Full Text] [Related]
10. Metalophil histiocytes in non-Hodgkin's lymphomas particularly in malignant proliferations of B-lymphocytes.
Van Unnik JA; De Weger RA
J Pathol; 1984 Dec; 144(4):241-51. PubMed ID: 6084055
[TBL] [Abstract][Full Text] [Related]
11. T cell rich B cell lymphoma (TCRBCL): study of sixteen cases with review of literature.
Muzaffar S; Pervez S; Kayani N; Soomro IN; Hasan SH
Indian J Pathol Microbiol; 1999 Jan; 42(1):15-23. PubMed ID: 10420680
[TBL] [Abstract][Full Text] [Related]
12. [Malignant and benign lymphomas: histologic classification and immunomorphologic studies. Results of 838 cases].
Radaszkiewicz T
Wien Klin Wochenschr; 1980 Dec; 92(23):819-33. PubMed ID: 6985528
[TBL] [Abstract][Full Text] [Related]
13. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
Tubbs RR; Fishleder A; Weiss RA; Savage RA; Sebek BA; Weick JK
Am J Pathol; 1983 Nov; 113(2):207-21. PubMed ID: 6605690
[TBL] [Abstract][Full Text] [Related]
14. [Flow cytometric analysis of surface phenotypes in B-cell non-Hodgkin's lymphoma].
Chubachi A
Rinsho Ketsueki; 1989 Dec; 30(12):2134-40. PubMed ID: 2516139
[TBL] [Abstract][Full Text] [Related]
15. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
Marder RJ; Variakojis D; Silver J; Epstein AL
Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections.
Rowlands DC; Hansel TT; Crocker J
J Pathol; 1990 Mar; 160(3):239-43. PubMed ID: 2139890
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
Kalyan K; Basu D; Soundararaghavan J
Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
[TBL] [Abstract][Full Text] [Related]
19. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
Krivolapov IuA
Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.
Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]